Shares of Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) have received a consensus rating of “Buy” from the eight ratings firms that are covering the company. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated […]
